Predictive performance of pharmacokinetic methods for phenytoin dosing: a multi-center evaluation in 282 patients with epilepsy

A retrospective study was conducted in 282 patients with epilepsy to assess the predictive performance of pharmacokinetic methods for individualizing dosage of phenytoin. Two population-based dosing methods (population clearance method and bayesian feedback method) and one individual-based method (the so-called linearized Michaelis-Menten method) were evaluated, when applicable, for single-point and/or 2-point dose predictions of phenytoin. In single-point predictions, we found a generally low percentage of dose calculations falling inside the +/- 10% range (48.9% and 51.1% for the population clearance and the bayesian methods, respectively). In 2-point predictions, the bayesian method was 'accurate' (dose within the +/- 10% range) in approximately 54.3% or 55.0% of cases (depending on the particular method of implementation adopted). An even worse percentage of 'accurate' dose predictions (38.3%) was obtained by using the linearized Michaelis-Menten method. Our data do not confirm results from previous studies indicating a generally good performance of pharmacokinetic methods for predicting phenytoin dosage.

[1]  I. Leppik,et al.  Increased clearance of phenytoin during infectious mononucleosis. , 1979, The New England journal of medicine.

[2]  J G Wagner.  New and simple method to predict dosage of drugs obeying simple Michaelis-Menten elimination kinetics and to distinguish such kinetics from simple first order and from parallel Michaelis-Menten and first order kinetics. , 1985, Therapeutic drug monitoring.

[3]  J W Taylor,et al.  Predicting Phenytoin Dosages Using Bayesian Feedback: A Comparison with Other Methods , 1983, Therapeutic drug monitoring.

[4]  I. Leppik,et al.  Compliance and variability of plasma phenytoin levels in epileptic patients , 1979 .

[5]  A. Richens,et al.  PHENYTOIN DOSAGE NOMOGRAM , 1975, The Lancet.

[6]  J. D. Robinson,et al.  Comparison of Eight Phenytoin Dosing Methods in Institutionalized Patients , 1985, Therapeutic drug monitoring.

[7]  W. Theodore,et al.  Phenytoin: The pseudosteady‐state phenomenon , 1984, Clinical pharmacology and therapeutics.

[8]  K Bachmann,et al.  A new approach to establishing individualized maintenance doses of phenytoin. , 1985, Therapeutic drug monitoring.

[9]  T. Jochsberger,et al.  Alternative Method for Predicting Phenytoin Levels , 1986, Drug intelligence & clinical pharmacy.

[10]  F C Robinson,et al.  A graphic method for predicting individual phenytoin levels in an office practice. , 1982, Therapeutic drug monitoring.

[11]  A Messori,et al.  A New Programmable Calculator Procedure for Individualizing Phenytoin Dosage , 1983, Drug intelligence & clinical pharmacy.

[12]  T. Jochsberger.  Precautions in the Use of Michaelis-Menten Kinetics in the Prediction of Phenytoin Levels , 1986, Drug intelligence & clinical pharmacy.

[13]  Peter W. Mullen,et al.  Optimal phenytoin therapy: A new technique for individualizing dosage , 1978, Clinical pharmacology and therapy.

[14]  A. Richens,et al.  Predicting Phenytoin Dose—A Revised Nomogram , 1979, Therapeutic drug monitoring.

[15]  A Messori,et al.  COMPARATIVE ANALYSIS OF THE PHARMACOKINETIC TECHNIQUES AVAILABLE FOR INDIVIDUALIZING PHENYTOIN DOSAGE , 1983, Journal of clinical and hospital pharmacy.

[16]  E. Perucca,et al.  Quality Control in Drug Measurement , 1980, Therapeutic drug monitoring.

[17]  S. Shorvon,et al.  Phenytoin Monotherapy for Epilepsy: A Long‐Term Prospective Study, Assisted by Serum Level Monitoring, in Previously Untreated Patients , 1981, Epilepsia.

[18]  I. Leppik,et al.  Altered phenytoin clearance with febrile illness , 1986, Neurology.

[19]  P. D’arcy.  Drug Interactions with Oral Contraceptives , 1986, Family planning information service.

[20]  T. Ludden,et al.  Individualization of phenytoin dosage regimens , 1977, Clinical pharmacology and therapeutics.

[21]  Cacek At.  Review of alterations in oral phenytoin bioavailability associated with formulation, antacids, and food. , 1986, Therapeutic drug monitoring.

[22]  T. Welty,et al.  A Comparison of Phenytoin Dosing Methods in Private Practice Seizure Patients , 1986, Epilepsia.

[23]  R. W. Foster,et al.  Comparative evaluation of six techniques for determining the Michaelis‐Menten parameters relating phenytoin dose and steady‐state serum concentrations , 1979, The Journal of pharmacy and pharmacology.

[24]  J. Bruni,et al.  Clinical utility of six methods of predicting phenytoin doses and plasma concentrations. , 1981, American journal of hospital pharmacy.

[25]  P. Blain,et al.  Steady-state Pharmacokinetics of Phenytoin from Routinely Collected Patient Data , 1983, Clinical pharmacokinetics.

[26]  Nina M. Graves,et al.  Phenytoin dosage predictions using population clearances , 1982 .